Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Interest & Investment Income (2016 - 2025)

Merit Medical Systems' Interest & Investment Income history spans 16 years, with the latest figure at $3.9 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 17.65% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $15.1 million, down 42.55%, while the annual FY2025 figure was $15.1 million, 42.55% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $3.9 million at Merit Medical Systems, up from $3.6 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7.6 million in Q2 2024 and bottomed at $92000.0 in Q2 2021.
  • The 5-year median for Interest & Investment Income is $346500.0 (2021), against an average of $2.2 million.
  • The largest annual shift saw Interest & Investment Income plummeted 77.97% in 2022 before it surged 5454.2% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at $101000.0 in 2021, then rose by 21.78% to $123000.0 in 2022, then surged by 1463.41% to $1.9 million in 2023, then skyrocketed by 146.54% to $4.7 million in 2024, then dropped by 17.65% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Interest & Investment Income are $3.9 million (Q4 2025), $3.6 million (Q3 2025), and $3.8 million (Q2 2025).